At Nuviva Medical Weight Loss, we are committed to transparency, patient safety, and full compliance with all applicable local, state, and federal regulations, including those established by the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC). The content presented on this website is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

1. Medical Supervision

All therapies offered at Nuviva—including GLP-1, GLP-1/GIP, and other peptide-based or compounded medications—are prescribed solely under the direction of a licensed healthcare provider following a comprehensive medical evaluation. No treatment is initiated without proper documentation, medical justification, and clinical oversight. All use of peptides—whether FDA-approved or not—is conducted under physician supervision and intended for investigational or therapeutic purposes only.

2. Use of Compounded and Investigational Medications

Nuviva may offer compounded peptide therapies including GLP-1 receptor agonists, dual GLP-1/GIP agonists, and other compounds when clinically appropriate. These may be:

• Compounded by licensed 503A or 503B pharmacies registered with the FDA and compliant with Current Good Manufacturing Practices (cGMP), or
• Sourced from U.S.-based research laboratories, if permitted and supported by clinical judgment.

These compounded formulations are not FDA-approved and have not undergone the same safety, efficacy, or quality testing required for FDA-approved medications. They are intended for physician-directed investigational use only and are not suitable for unsupervised use. Nuviva does not promote, dispense, or substitute brand-name drugs such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, nor does it make any claim that its compounded formulations are equivalent to these FDA-approved products.

3. Therapeutic Outcomes and Limitations

Individual results may vary. The effectiveness of any therapy—whether involving GLP-1, GLP-1/GIP, or other peptides—depends on multiple factors, including treatment adherence, diet, physical activity, health status, and metabolism.

Any statements regarding benefits for weight loss or metabolic health are based on clinical experience or emerging research and have not been evaluated by the FDA. These therapies are not intended to diagnose, treat, cure, or prevent any disease.

4. FTC Compliance & Testimonials

To remain compliant with FTC regulations:

• Nuviva makes no guarantees regarding specific health outcomes or weight loss results.
• Testimonials or success stories shared on the site reflect individual experiences only and should not be considered representative of typical results.
• All therapies offered are elective and voluntary, and patients retain the right to decline any recommended treatment.

5. Peptide Therapy Disclosure

Peptide therapies provided at Nuviva are considered off-label and investigational. This includes both FDA-approved peptides used for non-indicated purposes and non-FDA-approved peptides available through compounded formulations.
These products are offered only in the context of provider-guided, patient-specific medical decisions. They are not intended for diagnosis, treatment, cure, or disease prevention. Misuse of these products is strictly prohibited.

6. Educational Content Only

All materials on this website—including blog posts, downloads, videos, and service descriptions—are strictly for educational use. They do not replace a licensed medical provider’s judgment and should not be relied upon for decisions about diagnosis or treatment. If you are experiencing a medical emergency, call 911 or visit the nearest emergency facility immediately.

7. Telemedicine Services

Nuviva offers telehealth consultations in compliance with all applicable state and federal regulations. All remote medical services—including prescriptions and treatment plans—are delivered by providers licensed in the patient’s state of residence.

8. Liability Waiver

By visiting this website or participating in Nuviva programs, you acknowledge and accept the investigational nature of certain therapies and agree to release Nuviva, its providers, affiliates, and staff from any liability related to the use of compounded or off-label treatments.

Contact us

If you have any questions about this Privacy Policy or how your information is handled, please contact us at:

• Website: www.nuvivaweightloss.com/contact

10. Updates to This Disclaimer

This disclaimer may be updated periodically to reflect changes in law, clinical practice, or company policy. Please review this page regularly for the most current version.